ED arrests ex-Andhra Bank director in Rs 50-bn Sterling Biotech graft

Sterling Biotech had taken loans of over Rs 50 bn from a consortium of banks led by Andhra Bank which had turned NPAs

enforcement directorate, andhra bank
IANS New Delhi
Last Updated : Jan 13 2018 | 2:29 PM IST

The Enforcement Directorate (ED) has arrested a former Director of Andhra Bank in its ongoing money laundering probe in the alleged Rs 50 billion bank fraud case involving Gujarat-based pharmaceutical company Sterling Biotech, an official said on Saturday.

Anup Prakash Garg was arrested after day-long questioning on Friday under charges of Prevention of Money Laundering Act (PMLA), the official said.

Both the ED and the Central Bureau of Investigation (CBI) had named Garg in their criminal cases as an accused. The ED initiated a money laundering probe in the case taking cognisance of CBI FIR in the case.

The ED said it found during probe that "certain entries" in a diary seized by the Income Tax Department in 2011 showed various cash payments amounting to Rs 15.2 million made to one "Garg, Director, Andhra Bank" between 2008-2009 by the Sandesara brothers.

"Various cash payments were made to Garg, as reflected in the said entries, on the instructions of Sandesara brothers, by withdrawing cash from the bank accounts of several benami companies of the Sandesara brothers," it said.

The financial probe agency alleged Garg of infusing several crores of rupees of his unaccounted cash in various companies through many Kolkata-based bogus shell companies with the help of cash or cheque entry operators in Kolkata to launder the proceeds of crime obtained by him from the Sandesaras.

In November last year, the ED arrested a Delhi-based businessman Gagan Dhawan in connection with the case.

The CBI had booked Sterling Biotech, its directors Chetan Jayantilal Sandesara, Dipti Chetan Sandesara, Rajbhushan Omprakash Dixit, Nitin Jayantilal Sandesara and Vilas Joshi, chartered accountant Hemant Hathi, Garg and some unidentified persons in connection with the alleged bank fraud case.

Sterling Biotech had taken loans of over Rs 50 billion from a consortium of banks led by Andhra Bank which had turned into non-performing assets. A total pending dues of the group companies were Rs 53.83 billion as on December 31, 2016, alleged the CBI FIR.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 13 2018 | 1:46 PM IST

Next Story